Evaluating the Potential Benefit of Reduced PTV Margins for Low and Intermediate Risk Prostate Cancer Patients Using Real-Time Electromagnetic Tracking
Advances in Radiation Oncology - United States
doi 10.1016/j.adro.2018.06.004
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV